Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 23, 2026, Dr. Joe Xiao was appointed to the Board of Directors (the "Board") of Picard Medical, Inc. (the "Company") with a term set to expire at the 2026 annual meeting of stockholders. Dr. Xiao has also been appointed to the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee.

In connection with being appointed to the Board, Dr. Xiao entered into the Company's standard indemnification agreement for directors.

Dr. Xiao will receive compensation in accordance with the Company's existing compensation policy for non-employee directors, which is described under "The Board, Its Committees and Its Compensation - Director Compensation" in the Company's proxy statement filed with the Securities and Exchange Commission (the "SEC") on June 15, 2026. There are no arrangements or understandings between Dr. Xiao and any other person pursuant to which he was selected to serve on the Board. There are also no transactions or relationships between Dr. Xiao and the Company that would require disclosure under Item 404(a) of Regulation S-K.